Applied DNA Sciences Reports Fiscal First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil prices gain more than 3%, heading for weekly gain with focus on Middle East supply
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Vertiv shares fall on analyst downgrades and options bets
- Stocks edge lower as dollar heads for weekly loss
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
Applied DNA Sciences (APDN) Misses Q1 EPS by 10c
February 9, 2017 4:08 PM ESTApplied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.16), $0.10 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $903 thousand versus the consensus estimate of $1.66 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
... More


